Cassava Sciences News - SAVA

Company Name	Stock Ticker Symbol	Market	Type
Cassava Sciences Inc	SAVA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.268	1.34%	20.278	08:36:25

Open Price	Low Price	High Price	Close Price	Prev Close
				20.01

more quote information »

Recent News

Date	Time	Source	Heading
4/15/2024	09:20	GLOBE	Redemption Date Announced for Warrants
3/25/2024	09:13	GLOBE	Cassava Sciences Announces Completion of an Interim Safety..
3/04/2024	09:15	GLOBE	Cassava Sciences Announces Virtual Presentation at the..
2/28/2024	16:01	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/2024	09:22	EDGAR2	Form 8-K - Current report
2/28/2024	09:14	GLOBE	Cassava Sciences Reports Full-year 2023 Financial Results..
2/07/2024	09:20	EDGAR2	Form 8-K - Current report
2/07/2024	09:08	GLOBE	No Decline in Cognition Scores in Patients with Mild..
2/01/2024	16:00	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/26/2024	16:23	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/05/2024	09:12	GLOBE	Cassava Sciences Completes Dividend Distribution of Warrants..
1/03/2024	16:24	EDGAR2	Form CERT - Certification by an exchange approving..
1/03/2024	16:22	EDGAR2	Form 424B2 - Prospectus [Rule 424(b)(2)]
1/03/2024	16:18	EDGAR2	Form 8-A12B - Registration of securities [Section 12(b)]
1/03/2024	09:10	EDGAR2	Form 8-K - Current report
1/02/2024	09:10	EDGAR2	Form 8-A12G - Registration of securities [Section 12(g)]
12/12/2023	09:19	EDGAR2	Form 8-K - Current report
12/12/2023	09:13	GLOBE	Cassava Sciences Announces Dividend Distribution of Warrants..
12/11/2023	16:18	EDGAR2	Form 8-K - Current report
12/08/2023	17:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/07/2023	16:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/07/2023	16:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/07/2023	16:01	GLOBE	Cassava Sciences Appoints Three New Members to its Board of..
11/07/2023	09:19	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	09:08	EDGAR2	Form 8-K - Current report
11/07/2023	09:01	GLOBE	Cassava Sciences Reports Third Quarter 2023 Financial and..
11/06/2023	09:15	GLOBE	Cassava Sciences Completes Enrollment for Pivotal Phase 3..
10/25/2023	09:15	GLOBE	MRI Data Suggest Simufilam is Not Associated with..
10/13/2023	09:06	IHMARKETNEWS	Friday’s Wall Street Highlights: Dollar General, Microsoft,..
10/12/2023	23:43	GLOBE	Statement by Cassava Sciences Regarding an Internal CUNY..
10/05/2023	09:15	GLOBE	Cassava Sciences to Present at the Jefferies Biotech..
10/04/2023	18:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	18:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	18:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	09:00	GLOBE	Cassava Sciences Completes Patient Enrollment for Pivotal..
9/18/2023	09:15	GLOBE	Cassava Sciences Announces Positive Interim Safety Review of..
9/13/2023	16:17	EDGAR2	Form 8-K - Current report
9/11/2023	09:10	GLOBE	Cassava Sciences Announces Science Publication That Confirms..
9/06/2023	09:15	GLOBE	Cassava Sciences Invited to Present in Four Upcoming..
8/24/2023	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	16:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/03/2023	16:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	09:12	EDGAR2	Form 8-K - Current report
8/03/2023	09:07	GLOBE	Cassava Sciences Reports Q2 2023 Financial Results and..
7/05/2023	09:25	EDGAR2	Form 8-K - Current report
7/05/2023	09:15	GLOBE	Oral Simufilam Slowed Cognitive Decline in a Randomized..
6/27/2023	09:15	GLOBE	New Research Shows Simufilam Suppresses Overactive mTOR
6/12/2023	09:15	GLOBE	New Publication Highlights Basic Science Supporting..
6/01/2023	09:15	GLOBE	Cassava Sciences to Present at the Jefferies Global..